An immunoprecipitation coupled with fluorescent Western blot analysis for the characterization of a model secondary serum cardiac troponin I reference material

Clinica Chimica Acta

Volumn 412, Issue 1-2, 2011, Pages 107-111

  He, Hua Jun ^a   Lowenthal, Mark S ^a   Cole, Kenneth D ^a   Bunk, David ^a   Wang, Lili ^a  

^a NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

Author keywords

Concentration; Fluorescent Western blot; Human cardiac troponin I; Immunoprecipitation; Proteolytic fragments; Serum based reference material; Troponin SRM 2921

Indexed keywords

MONOCLONAL ANTIBODY; TROPONIN I;

AMINO TERMINAL SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; BINDING AFFINITY; BLOOD SAMPLING; CARBOXY TERMINAL SEQUENCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FLUORESCENCE ANALYSIS; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD CHEMICAL ANALYSIS; BLOTTING, WESTERN; CATTLE; CHEMILUMINESCENT MEASUREMENTS; HUMANS; IMMUNOASSAY; IMMUNOPRECIPITATION; MYOCARDIUM; PEPTIDE FRAGMENTS; REFERENCE STANDARDS; SPECTROMETRY, FLUORESCENCE; TROPONIN I;

EID: 78650511743     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.09.017     Document Type: Article

References (26)

1. Cummins B., Auckland M.L., Cummins P. Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J 1987, 113:1333-1344.
2. Thygesen K., Alpert J.S., White H.D. Universal definition of myocardial infarction. Circulation 2007, 116:2634-2653. on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction.
3. Panteghini M., Pagani F., Yeo K.T., et al. Committee on Standardization of Markers of Cardiac Damage of the IFCC. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004, 50:327-332.
4. Panteghini M. Assay-related issues in the measurement of cardiac troponins. Clin Chim Acta 2009, 402:88-93.
5. Panteghini M. The importance of analytical quality specifications for biomarker assays currently used in acute cardiac care. Acute Card Care 2006, 8:133-138.
6. Christenson R.H., Duh S.H., Apple F.S., et al. Toward standardization of cardiac troponin I measurements part II: assessing commutability of candidate reference materials and harmonization of cardiac troponin I assays. Clin Chem 2006, 52:1685-1692.
7. Katrukha A.G., Bereznikova A.V., Filatov V.L., et al. Degradation of cardiac troponin I: implication for reliable immunodetection. Clin Chem 1998, 44:2433-2440.
8. Gaze D.C., Collinson P.O. Multiple molecular forms of circulating cardiac troponin: analytical and clinical significance. Ann Clin Biochem 2008, 45:349-355.
9. McDonough J.L., Van Eyk J.E. Developing the next generation of cardiac markers: disease-induced modifications of troponin I. Prog Cardiovasc Dis 2004, 47:207-216.
10. Collinson P.O., Gaze D.C. Cardiac troponins in patients with renal failure: what are we measuring and when should we measure it?. Ann Clin Biochem 2009, 46:269-270.
11. Kim W.J., Lateraz O.F., Hock K.G., et al. Performance of a revised cardiac troponin method that minimizes interferences from heterophilic antibodies. Clin Chem 2002, 48:1028-1034.
12. Tate J., Ward G. Interferences in immunoassay. Clin Biochem Rev 2004, 25:105-120.
13. Panteghini M., Bunk D.M., Christenson R.H., et al. Standardization of troponin I measurements: an update. Clin Chem Lab Med 2008, 46:1501-1506.
14. hsTnI MAbs™. Hytest News; 2007.
15. Preparation and validation of commutable frozen human serum pools as secondary reference materials for cholesterol measurements procedures; approved guideline. NCCLS Document C37-A 1999, National Committee for Clinical Laboratory Standards, PA: NCCLS, Wayne.
16. Labugger R., Organ L., Collier C., Atar D., Van Eyk J.E. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation 2000, 102:1221-1226.
17. Madsen L.H., Christensen G., Lund T., et al. Time course of degradation of cardiac troponin I in patients with acute ST-elevation myocardial infarction: the ASSENT-2 troponin substudy. Circ Res 2006, 99:1141-1147.
18. Wang L., Bunk D., He H.J., Cole K. Removal of inhibitory effects in a serum cardiac troponin I immunoassay. Clin Chem 2009, 55:2055-2056.
19. Pettersson K., Eriksson S., Wittfooth S., Engström E., Nieminen M., Sinisalo J. Autoantibodies to cardiac troponin associate with higher initial concentrations and longer release of troponin I in acute coronary syndrome patients. Clin Chem 2009, 55:938-945.
20. Eriksson S., Halenius H., Pulkki K., Hellman J., Pettersson K. Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies. Clin Chem 2005, 51:839-847.
21. Malhotra A., Nakouzi A., Bowman J., Buttrick P. Expression and regulation of mutant forms of cardiac Tnl in reconstituted actomyosin system: role of kinase dependent phosphorylation. Mol Cell Biochem 1997, 170:99-107.
22. Harada K., Morimoto S. Inherited cardiomyopathies as a troponin disease. Jpn J Physiol 2004, 54:307-318.
23. Panteghini M., Gerhardt W., Apple F.S., Dati F., Ravkilde J., Wu A.H. Quality specifications for cardiac troponin assays. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Clin Chem Lab Med 2001, 39:175-179.
24. Panteghini M., Forest J.C. Standardization in laboratory medicine: new challenges. Clin Chim Acta 2005, 355:1-12.
25. Tate J., Bunk D.M., Christenson R.H., et al. Standardization of cardiac troponin I measurement: past and present. Pathology 2010, 42(5):402-408.
26. Panteghini M. Standardization of cardiac troponin I measurements: the way forward?. Clin Chem 2005, 51:1594-1597.